Predictors of Delayed Culture Conversion Among Ugandan Patients

Hdl Handle:
http://hdl.handle.net/10144/618909
Title:
Predictors of Delayed Culture Conversion Among Ugandan Patients
Authors:
Atwine, D; Orikiriza, P; Taremwa, I; Ayebare, A; Logoose, S; Mwanga-Amumpaire, J; Jindani, A; Bonnet, M
Journal:
BMC Infectious Diseases
Abstract:
Estimates of month-2 culture conversion, a proxy indicator of tuberculosis (TB) treatment efficacy in phase-2 trials can vary by culture-type and geographically with lower rates reported among African sites. The sub-study aimed at comparing TB detection rates of different culture media, within and across rifampicin-based regimens (R10, 15 and 20 mg/Kg) over a 6-month treatment follow-up period, and to establish predictors of month-2 culture non-conversion among HIV-negative TB patients enrolled at RIFATOX trial site in Uganda.
Publisher:
BioMed Central
Issue Date:
24-Apr-2017
URI:
http://hdl.handle.net/10144/618909
DOI:
10.1186/s12879-017-2335-7
PubMed ID:
28438118
Submitted date:
2017-05-08
Language:
en
ISSN:
1471-2334
Appears in Collections:
TB

Full metadata record

DC FieldValue Language
dc.contributor.authorAtwine, Den
dc.contributor.authorOrikiriza, Pen
dc.contributor.authorTaremwa, Ien
dc.contributor.authorAyebare, Aen
dc.contributor.authorLogoose, Sen
dc.contributor.authorMwanga-Amumpaire, Jen
dc.contributor.authorJindani, Aen
dc.contributor.authorBonnet, Men
dc.date.accessioned2017-05-08T18:17:09Z-
dc.date.available2017-05-08T18:17:09Z-
dc.date.issued2017-04-24-
dc.date.submitted2017-05-08-
dc.identifier.citationPredictors of Delayed Culture Conversion Among Ugandan Patients. 2017, 17 (1):299 BMC Infect. Dis.en
dc.identifier.issn1471-2334-
dc.identifier.pmid28438118-
dc.identifier.doi10.1186/s12879-017-2335-7-
dc.identifier.urihttp://hdl.handle.net/10144/618909-
dc.description.abstractEstimates of month-2 culture conversion, a proxy indicator of tuberculosis (TB) treatment efficacy in phase-2 trials can vary by culture-type and geographically with lower rates reported among African sites. The sub-study aimed at comparing TB detection rates of different culture media, within and across rifampicin-based regimens (R10, 15 and 20 mg/Kg) over a 6-month treatment follow-up period, and to establish predictors of month-2 culture non-conversion among HIV-negative TB patients enrolled at RIFATOX trial site in Uganda.en
dc.language.isoenen
dc.publisherBioMed Centralen
dc.rightsArchived with thanks to BMC Infectious Diseasesen
dc.titlePredictors of Delayed Culture Conversion Among Ugandan Patientsen
dc.identifier.journalBMC Infectious Diseasesen

Related articles on PubMed

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.